Thus, from a (patho)physiological point-of-view an increase in the membrane bound ACE2, the SARS-CoV-2 receptor, in the lungs will most likely increase susceptibility to COVID-19 [44], as it is dubious whether it will bolster the counter-regulatory RAS axis (Figure 2) [38,45]. Here, ACE2 is linked to COVID-19.